Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. - Contacts and Locations

Home

Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.

This study has been terminated.

Study NCT00463762. Last updated on August 23, 2007. Information provided by Pfizer

Please refer to this study by its ClinicalTrials.gov identifier: NCT00463762

Sponsors and Collaborators

Pfizer

Investigators


Study Director:	Pfizer CT.gov Call Center	Pfizer